This article was originally published in The Rose Sheet
Executive SummaryCoty inks deal with fashion house Balenciaga to develop and distribute fragrances under Balenciaga name, according to October 10 announcement. Partnership will renew Balenciaga's connection to fragrance - and allow it to "re-express" itself in the fragrance world - more than 60 years after launch of designer's Le Dix scent, company notes. Michele Scannavini, president of Coty Prestige, says Balenciaga's heritage "lends itself perfectly to Coty Prestige's designer portfolio" and acclaims Balenciaga as "a highly distinctive brand [that] embodies couture with a visionary style." Acquired by Gucci Group in 2001, Balenciaga currently creates men's and women's ready-to-wear, shoes and accessories and "is enjoying a very strong growth in all categories," according to the release
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.